PB 15 of 2011
National Health (Price and Special Patient Contribution) Amendment Determination 2011 (No. 2)1
National Health Act 1953
I, FELICITY McNEILL, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Determination under section 85B of the National Health Act 1953.
Dated 18 February 2011
 
 
 
 
 
 
 
 
 
 
 
FELICITY McNEILL
Acting First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health and Ageing
 
1          Name of Instrument
            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2011 (No. 2).
            (2)        This Instrument may also be cited as PB 15 of 2011.
2          Commencement
                        This Instrument commences on 1 March 2011.
3          Amendment of PB 109 of 2010
                        Schedule 1 amends PB 109 of 2010.
Schedule 1     Amendments
 
[1]        Schedule 1, entry for Bleomycin
            omit:
 
 
Injection
Blenoxane
10
439.63
903.27
 
[2]        Schedule 1, entry for Pindolol
            omit:
 
Tablet 5 mg
Oral
Visken 5
100
4.18
6.42
 
[3]        Schedule 2, entry for Naratriptan
            insert after the second paragraph in the column headed “Circumstances”:
 
 
 
 
Migraine attack in a patient where attacks in the past have usually failed to respond to analgesics, and where drug interactions are expected to occur with other suitable PBS-listed drugs.
 
 
 
 
 
 
 
 
 
 
 
 
 
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.  See http://www.frli.gov.au.